TrialMenopause (New York, N.Y.)2019

Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial.

David F Archer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.